HRP20231735T1 - Liječenje simptoma izazvanih menstrualnim ciklusom - Google Patents
Liječenje simptoma izazvanih menstrualnim ciklusom Download PDFInfo
- Publication number
- HRP20231735T1 HRP20231735T1 HRP20231735TT HRP20231735T HRP20231735T1 HR P20231735 T1 HRP20231735 T1 HR P20231735T1 HR P20231735T T HRP20231735T T HR P20231735TT HR P20231735 T HRP20231735 T HR P20231735T HR P20231735 T1 HRP20231735 T1 HR P20231735T1
- Authority
- HR
- Croatia
- Prior art keywords
- mmc
- kit
- unit dose
- use according
- menstrual cycle
- Prior art date
Links
- 208000024891 symptom Diseases 0.000 title claims 5
- 230000027758 ovulation cycle Effects 0.000 title claims 4
- QDNXSIYWHYGMCD-UHFFFAOYSA-N 2-(methylamino)-1-(3-methylphenyl)propan-1-one Chemical compound CNC(C)C(=O)C1=CC=CC(C)=C1 QDNXSIYWHYGMCD-UHFFFAOYSA-N 0.000 claims 21
- 206010027304 Menopausal symptoms Diseases 0.000 claims 3
- 230000003213 activating effect Effects 0.000 claims 1
- 239000005022 packaging material Substances 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
Claims (15)
1. Komplet koji sadrži najmanje jednu jediničnu dozu koja sadrži terapeutski učinkovitu količinu 3-metilmetkatinona (3-MMC) za upotrebu u liječenju najmanje jednog simptoma izazvanog menstruacijom kod subjekta i upute za primjenu navedenog 3-MMC-a prije, tijekom ili nakon vremena u kojem se očekuje da će se navedeni simptom izazvan menstrualnim ciklusom dogoditi, ili se dogodio, i ambalažni materijal.
2. Komplet za upotrebu prema patentnom zahtjevu 1, koji nadalje sadrži uređaj za određivanje vremena u kojem se očekuje da će se navedeni najmanje jedan simptom izazvan menstrualnim ciklusom dogoditi, ili se dogodio, u navedenom subjektu.
3. Komplet za upotrebu prema patentnom zahtjevu 1 ili 2, praćen digitalnim računalnim sučeljem za snimanje kronologije i karaktera navedenog najmanje jednog simptoma izazvanog menstrualnim ciklusom.
4. Komplet prema patentnom zahtjevu 3, pri čemu je navedeno sučelje aplikacija za mobilni telefon, komplet dalje sadrži crtični kod za preuzimanje ili aktiviranje navedene aplikacije.
5. Komplet za upotrebu prema bilo kojem od patentnih zahtjeva 1-4, pri čemu navedena jedinična doza sadrži između 5 i 100 mg 3-MMC.
6. Komplet za upotrebu prema bilo kojem od patentnih zahtjeva 1-4, pri čemu navedena jedinična doza sadrži između 10 i 60 mg 3-MMC.
7. Komplet za upotrebu prema bilo kojem od patentnih zahtjeva 1-4, pri čemu navedena jedinična doza sadrži 12,5 mg 3-MMC.
8. Komplet za upotrebu prema bilo kojem od patentnih zahtjeva 1-4, pri čemu navedena jedinična doza sadrži 25 mg 3-MMC.
9. Komplet za upotrebu prema bilo kojem od patentnih zahtjeva 1-4, pri čemu navedena jedinična doza sadrži 50 mg 3-MMC.
10. Komplet za upotrebu prema bilo kojem od patentnih zahtjeva 1-4, koji sadrži najmanje jednu jediničnu dozu od 12,5 mg 3-MMC i najmanje jednu jediničnu dozu od 25 mg 3-MMC.
11. Komplet za upotrebu prema bilo kojem od patentnih zahtjeva 1-4, koji sadrži najmanje jednu jediničnu dozu od 25 mg 3-MMC i najmanje jednu jediničnu dozu od 50 mg 3-MMC.
12. Komplet za upotrebu u liječenju najmanje jednog simptoma izazvanog premenopauzom, perimenopauzom i menopauzom kod subjekta kojem je to potrebno, a koji sadrži najmanje jednu jediničnu dozu koja sadrži terapeutski učinkovitu količinu 3-metilmetkatinona (3-MMC).
13. Komplet za upotrebu prema patentnom zahtjevu 12, pri čemu navedena jedinična doza sadrži između 5 i 100 mg 3-MMC, 10 i 60 mg 3-MMC ili 12,5 mg 3-MMC.
14. Komplet za upotrebu prema patentnom zahtjevu 12, koji sadrži najmanje jednu jediničnu dozu od 12,5 mg 3-MMC i najmanje jednu jediničnu dozu od 25 mg 3-MMC.
15. Komplet za upotrebu prema patentnom zahtjevu 12, koji sadrži najmanje jednu jediničnu dozu od 25 mg 3-MMC i najmanje jednu jediničnu dozu od 50 mg 3-MMC.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962891438P | 2019-08-26 | 2019-08-26 | |
| PCT/IB2020/057967 WO2021038460A1 (en) | 2019-08-26 | 2020-08-26 | Treatment of menstrual cycle-induced symptoms |
| EP20772102.8A EP4021433B1 (en) | 2019-08-26 | 2020-08-26 | Treatment of menstrual cycle-induced symptoms |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20231735T1 true HRP20231735T1 (hr) | 2024-03-15 |
Family
ID=72517274
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20231735TT HRP20231735T1 (hr) | 2019-08-26 | 2020-08-26 | Liječenje simptoma izazvanih menstrualnim ciklusom |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US11559502B2 (hr) |
| EP (1) | EP4021433B1 (hr) |
| JP (1) | JP2022545960A (hr) |
| KR (1) | KR20220069014A (hr) |
| CN (1) | CN114555070B (hr) |
| AU (1) | AU2020335372A1 (hr) |
| BR (1) | BR112022003686A2 (hr) |
| CA (1) | CA3152069A1 (hr) |
| ES (1) | ES2967484T3 (hr) |
| HR (1) | HRP20231735T1 (hr) |
| HU (1) | HUE064596T2 (hr) |
| IL (1) | IL290880A (hr) |
| MA (1) | MA56998B1 (hr) |
| MX (1) | MX2022002400A (hr) |
| PL (1) | PL4021433T3 (hr) |
| WO (1) | WO2021038460A1 (hr) |
| ZA (1) | ZA202203367B (hr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP20231735T1 (hr) | 2019-08-26 | 2024-03-15 | Period Pill Bv | Liječenje simptoma izazvanih menstrualnim ciklusom |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5389670A (en) * | 1993-12-21 | 1995-02-14 | Eli Lilly Company | Methods of inhibiting the symptoms of premenstrual syndrome/late luteal phase dysphoric disorder |
| MXPA04012740A (es) | 2002-07-02 | 2005-03-23 | Galileo Pharmaceuticals Inc | Composiciones y metodos para reduccion de sintomas inflamatorios y/o biomarcadores en pacientes femeninos. |
| US20040127409A1 (en) | 2002-11-07 | 2004-07-01 | Milkhaus Laboratory, Inc. | Method of treatment of psychological conditions by administration of nerve growth factor |
| US20070149451A1 (en) | 2003-11-17 | 2007-06-28 | Holmes David G | Combination of a dpp IV inhibitor and an antiobesity or appetite regulating agent |
| WO2006012563A2 (en) | 2004-07-23 | 2006-02-02 | The Regents Of The University Of California | Method for the treatment and diagnosis of certain psychiatric disorders related to the menstrual cycle |
| US20080262071A1 (en) | 2004-09-17 | 2008-10-23 | Timothy Dinan | Pindolol for the Treating Premenstrual Syndrome and Premenstrual Dysphoric Disorder |
| US20080207601A1 (en) * | 2005-04-07 | 2008-08-28 | Hythiam , Inc. | Methods of and Compositions For the Prevention of Anxiety, Substance Abuse, and Dependence |
| BRPI0608475A2 (pt) | 2005-04-22 | 2010-01-05 | Wyeth Corp | derivados de diidrobenzofurano e usos dos mesmos |
| GT200600159A (es) | 2005-04-22 | 2007-03-14 | Derivados benzodioxano y benzodioxolano y usos de los mismos | |
| US20070098819A1 (en) | 2005-11-02 | 2007-05-03 | Susan Thys-Jacobs | Micronutrient supplement with calcium, vitamin D or calcium & vitamin D combination for premenstrual syndrome, postpartum depression, depression and panic attacks |
| US20070255278A1 (en) | 2006-04-28 | 2007-11-01 | Nobis Rudolph H | Apparatus and method for deploying a cutting element during an endoscopic mucosal resection |
| US20080160083A1 (en) | 2007-01-03 | 2008-07-03 | Jarret Morrow | Composition and method for treatment of premenstrual symptoms |
| AU2009279372A1 (en) * | 2008-08-06 | 2010-02-11 | Gosforth Centre (Holdings) Pty Ltd | Compositions and methods for treating psychiatric disorders |
| WO2010054286A2 (en) | 2008-11-10 | 2010-05-14 | Auspex Pharmaceuticals, Inc. | Substituted hydroxyphenylamine compounds |
| US9119865B2 (en) | 2009-10-27 | 2015-09-01 | Lipogen Ltd. | Compositions and methods for alleviating symptoms associated with premenstrual syndrome and premenstrual dysphoric disorder |
| WO2013171146A1 (en) | 2012-05-15 | 2013-11-21 | Lts Lohmann Therapie-Systeme Ag | Oral film containing enteric release opiate resinate |
| BR102013013564A2 (pt) | 2013-05-31 | 2015-07-07 | Ems Sa | Composição para tratamento ou redução de sintomas relacionados à tensão pré-menstrual (tpm), transtorno disfórico pré-menstrual (tdpm), pré-menopausa, menopausa ou desordens hormonais femininas, forma farmacêutica contendo dita composição, processo para produzir dita forma farmacêutica e uso de dita composição |
| KR102262306B1 (ko) | 2013-07-04 | 2021-06-09 | (주)아모레퍼시픽 | 월경 전기 증후군 및 월경통 완화의 기능을 갖는 조성물 |
| US10575829B2 (en) | 2014-09-03 | 2020-03-03 | Earlysense Ltd. | Menstrual state monitoring |
| TWI774660B (zh) | 2016-03-08 | 2022-08-21 | 日商大塚製藥股份有限公司 | 女性特有之身體及/或精神不快症狀之改善劑 |
| WO2018125019A2 (en) * | 2016-12-30 | 2018-07-05 | Istanbul Üni̇versi̇tesi̇ | Use of some mirnas for the diagnosis and treatment of diseases associated with insulin |
| EP3661491A1 (en) | 2017-08-03 | 2020-06-10 | Mind Medicine, Inc. | Use of 3-methylmethcathinone |
| HRP20231735T1 (hr) | 2019-08-26 | 2024-03-15 | Period Pill Bv | Liječenje simptoma izazvanih menstrualnim ciklusom |
-
2020
- 2020-08-26 HR HRP20231735TT patent/HRP20231735T1/hr unknown
- 2020-08-26 PL PL20772102.8T patent/PL4021433T3/pl unknown
- 2020-08-26 EP EP20772102.8A patent/EP4021433B1/en active Active
- 2020-08-26 KR KR1020227009988A patent/KR20220069014A/ko unknown
- 2020-08-26 HU HUE20772102A patent/HUE064596T2/hu unknown
- 2020-08-26 ES ES20772102T patent/ES2967484T3/es active Active
- 2020-08-26 MX MX2022002400A patent/MX2022002400A/es unknown
- 2020-08-26 CA CA3152069A patent/CA3152069A1/en active Pending
- 2020-08-26 BR BR112022003686A patent/BR112022003686A2/pt unknown
- 2020-08-26 CN CN202080072247.8A patent/CN114555070B/zh active Active
- 2020-08-26 US US17/637,859 patent/US11559502B2/en active Active
- 2020-08-26 JP JP2022513642A patent/JP2022545960A/ja active Pending
- 2020-08-26 WO PCT/IB2020/057967 patent/WO2021038460A1/en active Application Filing
- 2020-08-26 MA MA56998A patent/MA56998B1/fr unknown
- 2020-08-26 AU AU2020335372A patent/AU2020335372A1/en active Pending
-
2022
- 2022-02-24 IL IL290880A patent/IL290880A/en unknown
- 2022-03-22 ZA ZA2022/03367A patent/ZA202203367B/en unknown
-
2023
- 2023-01-06 US US18/093,846 patent/US20230145635A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR20220069014A (ko) | 2022-05-26 |
| CN114555070A (zh) | 2022-05-27 |
| ZA202203367B (en) | 2023-10-25 |
| IL290880A (en) | 2022-04-01 |
| US20220265581A1 (en) | 2022-08-25 |
| EP4021433B1 (en) | 2023-10-04 |
| PL4021433T3 (pl) | 2024-03-11 |
| EP4021433A1 (en) | 2022-07-06 |
| MA56998B1 (fr) | 2023-12-29 |
| ES2967484T3 (es) | 2024-04-30 |
| CN114555070B (zh) | 2024-11-05 |
| CA3152069A1 (en) | 2021-03-04 |
| JP2022545960A (ja) | 2022-11-01 |
| US11559502B2 (en) | 2023-01-24 |
| MX2022002400A (es) | 2022-06-08 |
| US20230145635A1 (en) | 2023-05-11 |
| EP4021433C0 (en) | 2023-10-04 |
| AU2020335372A1 (en) | 2022-04-07 |
| BR112022003686A2 (pt) | 2022-05-24 |
| WO2021038460A1 (en) | 2021-03-04 |
| HUE064596T2 (hu) | 2024-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20171470T1 (hr) | Automatizirano raspakiravanje prijenosnih izvršnih datoteka | |
| HRP20231735T1 (hr) | Liječenje simptoma izazvanih menstrualnim ciklusom | |
| ECSP099448A (es) | Dispositivo de inhalación para medicamentos en forma de polvo | |
| JP2013503165A5 (hr) | ||
| CY1111369T1 (el) | Φαρμακευτικη συνθεση που περιλαμβανει 3-(3-διμεθυλαμινο-1-αιθυλ-2-μεθυλ-προπυλ)-φαινολη και παρακεταμολη | |
| AT267044B (de) | Gymnastik-Massagegerät, insbesondere Fußroller | |
| NI202100006A (es) | Formas farmacéuticas orales biodisponibles | |
| MA53277A (fr) | Composition contenant un agent mucolytique pour le traitement de l'hypersécrétion de mucus et dispositif pour le dosage de celle-ci | |
| FI3509595T3 (fi) | Hydroksipyridonaattiaktinidi-/lantanididekorporaatioaineiden formulaatioita | |
| AR044450A1 (es) | Composicion que comprende antagonistas de receptores de progesterona y antiestrogenos puros para la profilaxis y el tratamiento de enfermedades dependientes de hormonas | |
| MX2016009226A (es) | Combinaciones farmaceuticas. | |
| AR066231A1 (es) | Combinacion de antagonista del receptor de progesterona con atiestrogenos no esteroidales para usar en enfermedades mediadas por brca (genes supresores de tumores) | |
| RU2017129085A (ru) | Новый состав N-карбамоилметил-4-фенил-2-пирролидона | |
| CO2024000294A2 (es) | Composición que comprende cannabidiol e hidroxicloroquina en una cápsula combinada de dosis fija | |
| EA202092800A1 (ru) | Фармацевтическая композиция немедленного высвобождения для противовоспалительных лекарственных средств с фамотидином и карбонатом | |
| ES268807A1 (es) | Un dispositivo de disco limpiador para la limpieza del suelo de los tamices | |
| MA56448A (fr) | Compositions pharmaceutiques pour peptides co-agonistes du glucagon et du glp-1 | |
| MX2017016145A (es) | Composiciones farmaceuticas para la administracion oral de una dosis unitaria de un agente hipoglucemiante y una dosis unitaria baja de un agente anorexico. | |
| JP2015516449A5 (hr) | ||
| JP2015516450A5 (hr) | ||
| CN104257978A (zh) | 一种治疗附睾炎的中药组合物 | |
| EA202000300A1 (ru) | ФАРМАЦЕВТИЧЕСКИЙ НАБОР ДЛЯ КОМБИНИРОВАННОЙ ТЕРАПИИ COVID-19 (SARS-CoV-2) И СПОСОБ ЕГО ПРИМЕНЕНИЯ | |
| LING et al. | Expression of ATF4 in mouse endometrium during the estrus cycle | |
| CL2022000179A1 (es) | Terapia contra la ibd mediante inhibición de drd3 en linfocitos t reguladores | |
| JP2020000365A5 (hr) |